Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. (TELO): 2 pipeline candidates · 1 clinical trial. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
N/A
D/E 0.17 · 0% dilution
Lead: Phase 1/Phase 2
2 candidates
N/A
N/A
A transparent, data-derived signal for Telomir Pharmaceuticals, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$91.1M
Cash
—
Quarterly Burn
$1.8M
Runway
—
Revenue
—
Pipeline (2 candidates)
| Drug | Phase |
|---|---|
| telomir-1 | Phase 1/Phase 2 |
| zn-telomir | Phase 1/Phase 2 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
25
Total value held
$4.1M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 1,990,746 | $2.6M |
| blackrock, inc. | 289,198 | $376K |
| geode capital management, llc | 249,086 | $324K |
| vanguard fiduciary trust co | 135,541 | $176K |
| millennium management llc | 129,060 | $168K |
| state street corp | 58,600 | $76K |
| bank of new york mellon corp | 51,454 | $67K |
| northern trust corp | 41,844 | $54K |
| xtx topco ltd | 36,061 | $47K |
| osaic holdings, inc. | 35,795 | $47K |
Showing top 10 of 25 institutional holders of Telomir Pharmaceuticals, Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Telomir Pharmaceuticals, Inc.'s pipeline?
Telomir Pharmaceuticals, Inc. (TELO) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Telomir Pharmaceuticals, Inc.'s lead drug candidate?
Telomir Pharmaceuticals, Inc.'s most advanced tracked candidate is telomir-1 (Phase 1/Phase 2) for Oncology.
What is Telomir Pharmaceuticals, Inc.'s market capitalization?
Telomir Pharmaceuticals, Inc.'s market capitalization is approximately $91.1M.
Who is the CEO of Telomir Pharmaceuticals, Inc.?
Mr. Erez Aminov is the chief executive officer of Telomir Pharmaceuticals, Inc. (TELO).
Get the full picture on Telomir Pharmaceuticals, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.